By using bispecific antibodies targeting a tumor-associated antigen (TAA) on the cancer cells, and CD3 on the T-cells, it is possible to redirect and activate any circulating T-cells against tumor cells independently of the specificity of their TCR. Thanks to the bridging action of such TAAxCD3 bsAb, T-cells are brought in close proximity of the target cancer cells, leading to subsequent T-cell activation and T-cell–mediated killing of the tumor cells.
For more information on T-cell redirecting κλ-bodies, please visit Light Chain Bioscience.
Read our latest news
Newsletter August: From mitochondria to lipid droplets – investigating metabolism without labels
Welcome to the August edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Newsletter July: From immune cell activity to tumor cell metabolism: One platform, endless discoveries
Welcome to the July edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Newsletter June: Streamline immunotherapy discovery without labels
Welcome to the June edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Nanolive microscopes

3D CELL EXPLORER
Budget-friendly, easy-to-use, compact solution for high quality non-invasive 4D live cell imaging

3D CELL EXPLORER-fluo
Multimodal Complete Solution: combine high quality non-invasive 4D live cell imaging with fluorescence

CX-A
Automated live cell imaging: a unique walk-away solution for long-term live cell imaging of single cells and cell populations